revealed a non-, but nearly significant (hazard ratio 0.70; 95% CI 0.47–1.02) 30% risk reduction compared with placebo [ 92 ].
1
—
—
revealed a non-, but nearly significant (hazard ratio 0.70; 95% CI 0.47–1.02) 30% risk reduction compared with placebo [ 92 ].